RxDoctor Payments Data

Yonghua Zhang

Physician Assistant · Carmel, INNPI 1649828211

Payments from drug & device makers

$1,040in general payments, 2019–2025

Across 43 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$118
  • Lilly USA, LLC$105
  • AbbVie$105
  • Axsome Therapeutics, Inc.$103
  • Curonix LLC$100
  • Azurity Pharmaceuticals, Inc.$64
  • plus $445 from 18 others

What the payments were for

  • Food & beverage$1,040100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,040 in reported general payments places this provider in the 75th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$51,590
Medicare patients
119
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen762$19,145
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen667$14,818
Pregabalin218$6,242
Tizanidine Hcl349$5,466
BelbucaBuprenorphine Hcl11$5,450
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl24$4,989
MovantikNaloxegol Oxalate12$4,880
Gabapentin401$4,421
Oxycodone Hcl211$4,188
Naloxone Hcl68$3,833
Lidocaine30$2,110
Cyclobenzaprine Hcl264$1,705
Acetaminophen-CodeineAcetaminophen With Codeine17$1,008
Diclofenac Sodium53$957
Baclofen59$898

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$41$5,45011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →